Filter
47
Filtered Results: 47
Text search:
Gavi,
the
Coalition
for
Epidemic
Preparedness
Innovations
(CEPI)
and
WHO
Featured
Recommendations
8
New Publications
5
Language
Document type
Studies & Reports
15
Strategic & Response Plan
11
No document type
7
Manuals
4
Guidelines
4
Fact sheets
4
Situation Updates
1
Resource Platforms
1
Countries / Regions
Global
8
Syria
2
Burkina Faso
1
Nigeria
1
Congo, Democratic Republic of
1
Cameroon
1
Bangladesh
1
Brazil
1
Colombia
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Latin America and the Carribbean
1
Authors & Publishers
Publication Years
Category
Countries
7
Key Resources
6
Public Health
4
Pharmacy & Technologies
2
Capacity Building
1
Toolboxes
COVID-19
28
Health Financing Toolbox
5
Rapid Response
3
Global Health Education
2
AMR
2
Conflict
1
TB
1
Caregiver
1
Planetary Health
1
Pharmacy
1
Managing epidemics
recommended
Key facts about major deadly diseases.This manual provides concise and up-to-date knowledge on 15 infectious diseases that have the potential to become international threats, ... tips on how to respond to each of them.
You can download an interactive version directly at the website
http://www.who.int/emergencies/diseases/managing-epidemics/en/
Annual report on global preparednessfor health emergencies
The next pandemic is not a question of if, but when—and the world is woefully unprepa...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous v...
9 September 2020
In a snapshot, fair allocation of vaccines will occur in the following way:
An initial proportional allocation of doses to countries until all countries reach enough quantities to cover 20% of their population
This document...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccine...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies ... timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to ... most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current ... available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the manual is available in a compiled form and in several separate modules that can be consulted individually. For each module, specific training material is also available to facilitate implementation.
At least half of the world’s population does not have full coverage of essential health services. Health expenses push more than 100 million people into extreme poverty each and every year, forcin...
Available in Arabic, Chinese, English, French, Russian and Spanish. You can download a summary of the main report and background documents!
... report demonstrates that the current system—at both national and international levels— was not adequate to protect people from COVID-19. The time it took from the reporting of a cluster of cases of pneumonia of unknown origin in mid-late December 2019 to a Public Health Emergency of International Concern being declared was too long. February 2020 was also a lost month when many more countries could have taken steps to contain the spread of SARS-CoV-2 and forestall the global health, social, and economic catastrophe that continues its grip. The Panel finds that the system as it stands now is clearly unfit to prevent another novel and highly infectious pathogen, which could emerge at any time, from developing into a pandemic.
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – ... this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pandemic laid this inequity bare, it also saw the pharmaceutical industry develop and bring new vaccines and treat- ments to market at unprecedented speed. As the world emerges from the worst
of this crisis, pharmaceutical companies are now at an important juncture, where lessons learned from the pandemic can prove pivotal in finding solutions to bridge long-standing gaps in access to medicine in LMICs.
1 February 2021 to 31 January 2022
While much progress has been achieved over the past year, the Region of the Americas has stubbornly remained ... epicenter of the COVID-19 pandemic. PAHO is launching its 2021 COVID-19 Response Strategy and Donor Appeal to continue supporting Latin American and Caribbean countries and territories in their fight against COVID-19. This document outlines PAHO’s regional strategy for the year 2021 to sustain and scale-up the response to COVID‑19 pandemic in the Americas, suppress the community transmission of the virus and mitigate the longer-term health impact of the pandemic.
US$ 239 million is needed to support critical response efforts in the Americas between 1 January and 31 December 2021
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in...
In 2021, the humanitarian community continued to support those in need, placing protection at the centre of its response. Learning from and buildin...
COVID-19 & Vaccination
recommended
Issue Brief no.8. January 18,2021
Vaccination against the spread of the SARS-CoV-2 virus represents a milestone in the fight against ... pandemic. Good communication and education of the population is essential for the success of the vaccination. Below is some information on vaccination strategies, implementation of the vaccination, ethical considerations, as well as educational materials in English and other languages.
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of ... deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisive role in restricting fair access to a life-saving health product. This report focuses on six leading vaccine developers, AstraZeneca, BioNTech, Johnson & Johnson, Moderna, Novavax and Pfizer, assessing each company’s human rights policy, pricing structure, records on intellectual property, knowledge and technology sharing, allocation of available vaccine doses and transparency.
Available in Arabic, English, French, German and Spanish
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless ... world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
